OTCMKTS:CVAT Cavitation Technologies (CVAT) Stock Price, News & Analysis $0.02 0.00 (-15.50%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Stock Analysis Stock AnalysisChartFinancialsSEC FilingsShort Interest About Cavitation Technologies Stock (OTCMKTS:CVAT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CVAT alerts:Sign Up Key Stats Today's Range$0.02▼$0.0250-Day Range$0.01▼$0.0252-Week Range$0.00▼$0.02Volume108,252 shsAverage Volume248,916 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCavitation Technologies, Inc. develops, patents, and commercializes proprietary technology for use in the processing of various industrial and consumer-oriented fluids in the United States. It provides Nano Reactor and Nano Neutralization Systems for refining vegetable oils, such as soybean, rapeseed, canola, and palm oil. The company also develops technology-based systems for various markets, including renewable fuels, water treatment, wines and spirits enhancement, algae oil extraction, water-oil emulsions, and crude oil yield enhancement, as well as small home appliances. Cavitation Technologies, Inc. was founded in 2007 and is headquartered in Chatsworth, California.Read More… Cavitation Technologies Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks5th Percentile Overall ScoreCVAT MarketRank™: Cavitation Technologies scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Cavitation Technologies. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cavitation Technologies is -1.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cavitation Technologies is -1.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares ShortedShort Interest Ratio / Days to CoverCavitation Technologies has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cavitation Technologies has recently decreased by 21.19%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCavitation Technologies does not currently pay a dividend.Dividend GrowthCavitation Technologies does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares ShortedShort Interest Ratio / Days to CoverCavitation Technologies has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cavitation Technologies has recently decreased by 21.19%, indicating that investor sentiment is improving significantly. News and Social Media0.0 / 5News SentimentN/A News Coverage This WeekMarketBeat has tracked 1 news article for Cavitation Technologies this week, compared to 0 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cavitation Technologies insiders have not sold or bought any company stock.Percentage Held by Insiders28.11% of the stock of Cavitation Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 8.53% of the stock of Cavitation Technologies is held by institutions.Read more about Cavitation Technologies' insider trading history. Receive CVAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cavitation Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address CVAT Stock News HeadlinesCavitation Technologies (OTCMKTS:CVAT) Shares Cross Above 50 Day Moving Average - What's Next?December 21 at 4:19 AM | americanbankingnews.comCavitation Technologies, Inc. Provides Corporate Update and Letter to Shareholders, Goals for Fiscal Year 2025, and Recent Transaction With Desmet Belgium, SAOctober 28, 2024 | globenewswire.comWall Street Icon: “You must get on the right side of this thing”I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.December 22, 2024 | InvestorPlace (Ad)Nova Scotia Power crew on the ground assisting with power restoration in TampaOctober 14, 2024 | ca.finance.yahoo.comCitrus waste converted to biopolymers using cavitationSeptember 27, 2024 | msn.comReview: Atomic Maven 103 CTiSeptember 6, 2024 | yahoo.comCavitation Technologies Inc.August 28, 2024 | wsj.comCavitation Technologies Enhances Fluid Processing Efficiency with Green TechApril 4, 2024 | finance.yahoo.comSee More Headlines CVAT Stock Analysis - Frequently Asked Questions How have CVAT shares performed this year? Cavitation Technologies' stock was trading at $0.0163 on January 1st, 2024. Since then, CVAT shares have increased by 3.7% and is now trading at $0.0169. View the best growth stocks for 2024 here. How do I buy shares of Cavitation Technologies? Shares of CVAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Cavitation Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cavitation Technologies investors own include Adamis Pharmaceuticals (ADMP), Co-Diagnostics (CODX), iBio (IBIO), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), Altimmune (ALT) and Digital Ally (DGLY). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorIndustrials Industry Specialty Industrial Machinery Sub-IndustryAgriculture Current SymbolOTCMKTS:CVAT CUSIPN/A CIK1376793 Webwww.ctinanotech.com Phone(818) 718-0905FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (OTCMKTS:CVAT) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cavitation Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cavitation Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.